Cargando…

PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL

Detalles Bibliográficos
Autores principales: Risitano, Antonio Maria, Araten, David J, Kuter, David, Patel, Bhumika J, de Latour, Régis Peffault, Dahlke, Marion, Garito, Tania, LI, Shujie, Maitra, Samopriyo, Kulasekararaj, Austin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428707/
http://dx.doi.org/10.1097/01.HS9.0000975052.08587.b7
_version_ 1785090533525291008
author Risitano, Antonio Maria
Araten, David J
Kuter, David
Patel, Bhumika J
de Latour, Régis Peffault
Dahlke, Marion
Garito, Tania
LI, Shujie
Maitra, Samopriyo
Kulasekararaj, Austin
author_facet Risitano, Antonio Maria
Araten, David J
Kuter, David
Patel, Bhumika J
de Latour, Régis Peffault
Dahlke, Marion
Garito, Tania
LI, Shujie
Maitra, Samopriyo
Kulasekararaj, Austin
author_sort Risitano, Antonio Maria
collection PubMed
description
format Online
Article
Text
id pubmed-10428707
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104287072023-08-17 PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL Risitano, Antonio Maria Araten, David J Kuter, David Patel, Bhumika J de Latour, Régis Peffault Dahlke, Marion Garito, Tania LI, Shujie Maitra, Samopriyo Kulasekararaj, Austin Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428707/ http://dx.doi.org/10.1097/01.HS9.0000975052.08587.b7 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Risitano, Antonio Maria
Araten, David J
Kuter, David
Patel, Bhumika J
de Latour, Régis Peffault
Dahlke, Marion
Garito, Tania
LI, Shujie
Maitra, Samopriyo
Kulasekararaj, Austin
PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL
title PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL
title_full PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL
title_fullStr PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL
title_full_unstemmed PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL
title_short PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL
title_sort pb2063: appulse-pnh: a phase iiib trial to evaluate the efficacy and safety of switching to iptacopan in patients with paroxysmal nocturnal hemoglobinuria (pnh) on anti-c5 therapy with hemoglobin >10g/dl
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428707/
http://dx.doi.org/10.1097/01.HS9.0000975052.08587.b7
work_keys_str_mv AT risitanoantoniomaria pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl
AT aratendavidj pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl
AT kuterdavid pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl
AT patelbhumikaj pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl
AT delatourregispeffault pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl
AT dahlkemarion pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl
AT garitotania pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl
AT lishujie pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl
AT maitrasamopriyo pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl
AT kulasekararajaustin pb2063appulsepnhaphaseiiibtrialtoevaluatetheefficacyandsafetyofswitchingtoiptacopaninpatientswithparoxysmalnocturnalhemoglobinuriapnhonantic5therapywithhemoglobin10gdl